{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:05:18Z","timestamp":1787501118822,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004721","name":"The University of Tokyo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004721","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Radiol"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and purpose<\/jats:title>\n                    <jats:p>Loss of skeletal muscle mass is increasingly recognized as a poor prognostic indicator in patients with cancer, including those with head and neck squamous cell carcinoma (HNSCC). Emerging evidence suggests that the muscle area measured at the third cervical vertebra (C3) on CT serves as a practical surrogate for whole-body muscle status. This study aimed to evaluate the prognostic significance of C3-level body composition parameters in patients with HNSCC undergoing definitive radiotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>A total of 283 consecutive patients with HNSCC treated with definitive radiotherapy between 2013 and 2023 were retrospectively analyzed. Pre-treatment CT scans were used to assess six body composition metrics at the C3 level: skeletal muscle area (SMA), mean skeletal muscle density, visceral adipose tissue area, subcutaneous adipose tissue area, visceral-to-subcutaneous fat ratio, and skeletal muscle fat infiltration index. Patients were stratified into high and low groups based on sex-specific median values. Associations between each body composition metric (high vs. low) and survival outcomes were assessed using univariate and multivariate analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The cohort included 238 males and 45 females, with a median age of 67\u00a0years. Survival analysis showed a median follow-up period of 39.3\u00a0months. The 3-year overall survival (OS) rate for the entire cohort was 81.6%, and the 3-year progression free survival rate was 60.8%. In univariate analysis, only low SMA was significantly associated with poorer OS (hazard ratio: 1.841,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.027). The median SMA was 35.0 cm\n                      <jats:sup>2<\/jats:sup>\n                      for males and 23.5 cm\n                      <jats:sup>2<\/jats:sup>\n                      for females. In multivariate analysis, low SMA remained an independent predictor of reduced OS (hazard ratio: 1.851,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.028), along with clinical stage and chemotherapy status.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Among the CT-derived body composition parameters assessed at the C3 level, low SMA was the only significant independent predictor of OS in patients with HNSCC receiving definitive radiotherapy. These findings support the clinical relevance of SMA assessment as a straightforward and robust prognostic biomarker and underscore the need for further investigation into the prognostic potential of other body composition metrics.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11604-025-01888-1","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:32:39Z","timestamp":1759483959000},"page":"423-431","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical impact of computed tomography-measured skeletal muscle status at the third cervical vertebra on definitive radiotherapy outcomes for head and neck squamous cell carcinoma"],"prefix":"10.1007","volume":"44","author":[{"given":"Yuki","family":"Kasuga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4393-1828","authenticated-orcid":false,"given":"Atsuto","family":"Katano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanari","family":"Minamitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouhei","family":"Hanaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Yamamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenya","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideomi","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Gonoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"issue":"3","key":"1888_CR1","doi-asserted-by":"publisher","first-page":"109282","DOI":"10.1016\/j.isci.2024.109282","volume":"27","author":"T Zhou","year":"2024","unstructured":"Zhou T, Huang W, Wang X, Zhang J, Zhou E, Tu Y, et al. Global burden of head and neck cancers from 1990 to 2019. iScience. 2024;27(3):109282. https:\/\/doi.org\/10.1016\/j.isci.2024.109282.","journal-title":"iScience"},{"issue":"3","key":"1888_CR2","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.canep.2015.02.004","volume":"39","author":"E Leoncini","year":"2015","unstructured":"Leoncini E, Vukovic V, Cadoni G, Pastorino R, Arzani D, Bosetti C, et al. Clinical features and prognostic factors in patients with head and neck cancer: results from a multicentric study. Cancer Epidemiol. 2015;39(3):367\u201374. https:\/\/doi.org\/10.1016\/j.canep.2015.02.004.","journal-title":"Cancer Epidemiol"},{"issue":"6","key":"1888_CR3","doi-asserted-by":"publisher","first-page":"458","DOI":"10.14639\/0392-100x-1246","volume":"37","author":"G Cadoni","year":"2017","unstructured":"Cadoni G, Giraldi L, Petrelli L, Pandolfini M, Giuliani M, Paludetti G, et al. Prognostic factors in head and neck cancer: a 10-year retrospective analysis in a single-institution in Italy. Acta Otorhinolaryngol Ital. 2017;37(6):458\u201366. https:\/\/doi.org\/10.14639\/0392-100x-1246.","journal-title":"Acta Otorhinolaryngol Ital"},{"issue":"1","key":"1888_CR4","doi-asserted-by":"publisher","first-page":"17805","DOI":"10.1038\/s41598-017-18233-w","volume":"7","author":"A Katano","year":"2017","unstructured":"Katano A, Takahashi W, Yamashita H, Yamamoto K, Ando M, Yoshida M, et al. The impact of elevated C-reactive protein level on the prognosis for oro-hypopharynx cancer patients treated with radiotherapy. Sci Rep. 2017;7(1):17805. https:\/\/doi.org\/10.1038\/s41598-017-18233-w.","journal-title":"Sci Rep"},{"issue":"5","key":"1888_CR5","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1002\/hed.25075","volume":"40","author":"MA Mascarella","year":"2018","unstructured":"Mascarella MA, Mannard E, Silva SD, Zeitouni A. Neutrophil-to-lymphocyte ratio in head and neck cancer prognosis: a systematic review and meta-analysis. Head Neck. 2018;40(5):1091\u2013100. https:\/\/doi.org\/10.1002\/hed.25075.","journal-title":"Head Neck"},{"issue":"11","key":"1888_CR6","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1002\/hed.25324","volume":"40","author":"T Tham","year":"2018","unstructured":"Tham T, Bardash Y, Herman SW, Costantino PD. Neutrophil-to-lymphocyte ratio as a prognostic indicator in head and neck cancer: a systematic review and meta-analysis. Head Neck. 2018;40(11):2546\u201357. https:\/\/doi.org\/10.1002\/hed.25324.","journal-title":"Head Neck"},{"key":"1888_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/nu14142958","author":"S Salas","year":"2022","unstructured":"Salas S, Cottet V, Dossus L, Fassier P, Ginhac J, Latino-Martel P, et al. Nutritional factors during and after cancer: impacts on survival and quality of life. Nutrients. 2022. https:\/\/doi.org\/10.3390\/nu14142958.","journal-title":"Nutrients"},{"issue":"1","key":"1888_CR8","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1186\/s12967-022-03696-x","volume":"20","author":"B Zhang","year":"2022","unstructured":"Zhang B, Li Y, Chen Y. Prognosis-related nutritional score for cancer patients (PRNS): a clinical nutritional score derived from a retrospective cohort study. J Transl Med. 2022;20(1):477. https:\/\/doi.org\/10.1186\/s12967-022-03696-x.","journal-title":"J Transl Med"},{"key":"1888_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13040753","author":"S Thureau","year":"2021","unstructured":"Thureau S, Lebret L, Lequesne J, Cabourg M, Dandoy S, Gouley C, et al. Prospective evaluation of sarcopenia in head and neck cancer patients treated with radiotherapy or radiochemotherapy. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13040753.","journal-title":"Cancers (Basel)"},{"key":"1888_CR10","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.tipsro.2020.10.001","volume":"16","author":"M Anjanappa","year":"2020","unstructured":"Anjanappa M, Corden M, Green A, Roberts D, Hoskin P, McWilliam A, et al. Sarcopenia in cancer: risking more than muscle loss. Tech Innov Patient Support Radiat Oncol. 2020;16:50\u20137. https:\/\/doi.org\/10.1016\/j.tipsro.2020.10.001.","journal-title":"Tech Innov Patient Support Radiat Oncol"},{"issue":"9","key":"1888_CR11","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1007\/s11604-024-01587-3","volume":"42","author":"T Liu","year":"2024","unstructured":"Liu T, Wang G, Chen C, He L, Wang R. Prognostic value of sarcopenia in the patients with locally advanced nasopharyngeal carcinoma. Jpn J Radiol. 2024;42(9):1047\u201357. https:\/\/doi.org\/10.1007\/s11604-024-01587-3.","journal-title":"Jpn J Radiol"},{"issue":"5","key":"1888_CR12","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s11604-022-01369-9","volume":"41","author":"H Yuan","year":"2023","unstructured":"Yuan H, Tan X, Sun X, He L, Li D, Jiang L. Role of (18)F-FDG PET\/CT and sarcopenia in untreated non-small cell lung cancer with advanced stage. Jpn J Radiol. 2023;41(5):521\u201330. https:\/\/doi.org\/10.1007\/s11604-022-01369-9.","journal-title":"Jpn J Radiol"},{"issue":"1","key":"1888_CR13","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41598-020-79471-z","volume":"11","author":"BA Derstine","year":"2021","unstructured":"Derstine BA, Holcombe SA, Ross BE, Wang NC, Su GL, Wang SC. Optimal body size adjustment of L3 CT skeletal muscle area for sarcopenia assessment. Sci Rep. 2021;11(1):279. https:\/\/doi.org\/10.1038\/s41598-020-79471-z.","journal-title":"Sci Rep"},{"key":"1888_CR14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.oraloncology.2016.09.006","volume":"62","author":"JE Swartz","year":"2016","unstructured":"Swartz JE, Pothen AJ, Wegner I, Smid EJ, Swart KM, de Bree R, et al. Feasibility of using head and neck CT imaging to assess skeletal muscle mass in head and neck cancer patients. Oral Oncol. 2016;62:28\u201333. https:\/\/doi.org\/10.1016\/j.oraloncology.2016.09.006. (Epub 20161003 PubMed PMID: 27865369).","journal-title":"Oral Oncol"},{"issue":"1","key":"1888_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.radonc.2017.10.016","volume":"126","author":"V Gr\u00e9goire","year":"2018","unstructured":"Gr\u00e9goire V, Evans M, Le QT, Bourhis J, Budach V, Chen A, et al. Delineation of the primary tumour clinical target volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines. Radiother Oncol. 2018;126(1):3\u201324. https:\/\/doi.org\/10.1016\/j.radonc.2017.10.016.","journal-title":"Radiother Oncol"},{"issue":"1","key":"1888_CR16","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.radonc.2013.10.010","volume":"110","author":"V Gr\u00e9goire","year":"2014","unstructured":"Gr\u00e9goire V, Ang K, Budach W, Grau C, Hamoir M, Langendijk JA, et al. Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. Radiother Oncol. 2014;110(1):172\u201381. https:\/\/doi.org\/10.1016\/j.radonc.2013.10.010.","journal-title":"Radiother Oncol"},{"key":"1888_CR17","doi-asserted-by":"publisher","first-page":"812159","DOI":"10.3389\/fonc.2022.812159","volume":"12","author":"B Olson","year":"2022","unstructured":"Olson B, Edwards J, Degnin C, Santucci N, Buncke M, Hu J, et al. Establishment and validation of pre-therapy cervical vertebrae muscle quantification as a prognostic marker of sarcopenia in patients with head and neck cancer. Front Oncol. 2022;12:812159. https:\/\/doi.org\/10.3389\/fonc.2022.812159.","journal-title":"Front Oncol"},{"key":"1888_CR18","doi-asserted-by":"publisher","first-page":"12.04.24318458","DOI":"10.1101\/2024.12.04.24318458","volume":"2024","author":"N Akamatsu","year":"2024","unstructured":"Akamatsu N, Gonoi W, Hanaoka S, Inui S, Kurokawa M, Taguchi S, et al. Effects of contrast-medium and vertebral measurement level on computed tomography-based body composition parameters of skeletal muscle and adipose tissue. medRxiv. 2024;2024:12.04.24318458. https:\/\/doi.org\/10.1101\/2024.12.04.24318458.","journal-title":"medRxiv"},{"issue":"10","key":"1888_CR19","doi-asserted-by":"publisher","first-page":"4887","DOI":"10.21873\/anticanres.15994","volume":"42","author":"S Kise","year":"2022","unstructured":"Kise S, Arakaki Y, Kudaka W, Ariga T, Kinjo N, Kohatu H, et al. Sarcopenia is an independent prognostic factor for squamous cell carcinoma of the cervix treated with concurrent chemoradiotherapy. Anticancer Res. 2022;42(10):4887\u201393. https:\/\/doi.org\/10.21873\/anticanres.15994.","journal-title":"Anticancer Res"},{"issue":"2","key":"1888_CR20","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1177\/03008916231212382","volume":"110","author":"CL Deantoni","year":"2024","unstructured":"Deantoni CL, Mirabile A, Chiara A, Giannini L, Midulla M, Del Vecchio A, et al. Impact of low skeletal muscle mass in oropharyngeal cancer patients treated with radical chemo-radiotherapy: a mono-institutional experience. Tumori. 2024;110(2):116\u201323. https:\/\/doi.org\/10.1177\/03008916231212382.","journal-title":"Tumori"},{"key":"1888_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14225536","author":"E Haehl","year":"2022","unstructured":"Haehl E, Alvino L, R\u00fchle A, Zou J, Fabian A, Grosu AL, et al. Sarcopenia as a prognostic marker in elderly head and neck squamous cell carcinoma patients undergoing (chemo-)radiation. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14225536.","journal-title":"Cancers (Basel)"},{"key":"1888_CR22","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.radonc.2020.03.014","volume":"147","author":"MI van Rijn-Dekker","year":"2020","unstructured":"van Rijn-Dekker MI, van den Bosch L, van den Hoek JGM, Bijl HP, van Aken ESM, van der Hoorn A, et al. Impact of sarcopenia on survival and late toxicity in head and neck cancer patients treated with radiotherapy. Radiother Oncol. 2020;147:103\u201310. https:\/\/doi.org\/10.1016\/j.radonc.2020.03.014.","journal-title":"Radiother Oncol"},{"issue":"10","key":"1888_CR23","doi-asserted-by":"publisher","first-page":"e0259288","DOI":"10.1371\/journal.pone.0259288","volume":"16","author":"Y Takenaka","year":"2021","unstructured":"Takenaka Y, Takemoto N, Oya R, Inohara H. Prognostic impact of sarcopenia in patients with head and neck cancer treated with surgery or radiation: a meta-analysis. PLoS ONE. 2021;16(10):e0259288. https:\/\/doi.org\/10.1371\/journal.pone.0259288.","journal-title":"PLoS ONE"},{"issue":"7","key":"1888_CR24","doi-asserted-by":"publisher","first-page":"e0254844","DOI":"10.1371\/journal.pone.0254844","volume":"16","author":"JK Yoon","year":"2021","unstructured":"Yoon JK, Jang JY, An YS, Lee SJ. Skeletal muscle mass at C3 may not be a strong predictor for skeletal muscle mass at L3 in sarcopenic patients with head and neck cancer. PLoS ONE. 2021;16(7):e0254844. https:\/\/doi.org\/10.1371\/journal.pone.0254844.","journal-title":"PLoS ONE"},{"issue":"11","key":"1888_CR25","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1200\/jco.2017.74.9457","volume":"36","author":"V Noronha","year":"2018","unstructured":"Noronha V, Joshi A, Patil VM, Agarwal J, Ghosh-Laskar S, Budrukkar A, et al. Once-a-week versus once-every-3-weeks cisplatin chemoradiation for locally advanced head and neck cancer: a phase III randomized noninferiority trial. J Clin Oncol. 2018;36(11):1064\u201372. https:\/\/doi.org\/10.1200\/jco.2017.74.9457.","journal-title":"J Clin Oncol"},{"issue":"18","key":"1888_CR26","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1200\/jco.21.01293","volume":"40","author":"N Kiyota","year":"2022","unstructured":"Kiyota N, Tahara M, Mizusawa J, Kodaira T, Fujii H, Yamazaki T, et al. Weekly Cisplatin plus radiation for postoperative head and neck cancer (JCOG1008): a multicenter, noninferiority, phase II\/III randomized controlled trial. J Clin Oncol. 2022;40(18):1980\u201390. https:\/\/doi.org\/10.1200\/jco.21.01293.","journal-title":"J Clin Oncol"},{"issue":"6","key":"1888_CR27","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1056\/NEJMoa053422","volume":"354","author":"JA Bonner","year":"2006","unstructured":"Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med. 2006;354(6):567\u201378. https:\/\/doi.org\/10.1056\/NEJMoa053422. (PubMed PMID: 16467544).","journal-title":"N Engl J Med"},{"issue":"2","key":"1888_CR28","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1080\/01635581.2022.2138468","volume":"75","author":"B Vangelov","year":"2023","unstructured":"Vangelov B, Bauer J, Moses D, Smee R. Comparison of skeletal muscle changes at three vertebral levels following radiotherapy in patients with Oropharyngeal Carcinoma. Nutr Cancer. 2023;75(2):572\u201381. https:\/\/doi.org\/10.1080\/01635581.2022.2138468.","journal-title":"Nutr Cancer"},{"issue":"3","key":"1888_CR29","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s11547-022-01450-3","volume":"127","author":"AS Tagliafico","year":"2022","unstructured":"Tagliafico AS, Bignotti B, Torri L, Rossi F. Sarcopenia: how to measure, when and why. Radiol Med. 2022;127(3):228\u201337. https:\/\/doi.org\/10.1007\/s11547-022-01450-3.","journal-title":"Radiol Med"},{"issue":"6","key":"1888_CR30","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1007\/s11604-024-01724-y","volume":"43","author":"E Topkan","year":"2025","unstructured":"Topkan E, Somay E, Senyurek S. The presence of myopenia alone is not sufficient for a diagnosis of sarcopenia. Jpn J Radiol. 2025;43(6):1044\u20135. https:\/\/doi.org\/10.1007\/s11604-024-01724-y.","journal-title":"Jpn J Radiol"}],"container-title":["Japanese Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-025-01888-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11604-025-01888-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-025-01888-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T06:35:56Z","timestamp":1769841356000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11604-025-01888-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1888"],"URL":"https:\/\/doi.org\/10.1007\/s11604-025-01888-1","relation":{},"ISSN":["1867-1071","1867-108X"],"issn-type":[{"value":"1867-1071","type":"print"},{"value":"1867-108X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"13 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The requirement for informed consent was waived due to the retrospective nature of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}